SYNERGY PHARMACEUTICALS, INC.·4

Dec 8, 4:27 PM ET

Shailubhai Kunwar 4

4 · SYNERGY PHARMACEUTICALS, INC. · Filed Dec 8, 2011

Insider Transaction Report

Form 4
Period: 2011-12-06
Shailubhai Kunwar
Chief Scientific Officer
Transactions
  • Purchase

    Units

    2011-12-06$8.00/sh+12,788$102,30412,788 total
    Common Stock and Warrants (38,364 underlying)
Footnotes (3)
  • [F1]Dr. Shailubhai purchased 12,788 units of the issuer in a public offering at a purchase price of $8.00 per unit. Each unit consists of two shares of common stock and one common stock purchase warrant.
  • [F2]The common stock and warrants included in the units will not be separately transferable until the earlier of (i) the exercise in full of the underwriters' overallotment option or (ii) January 15, 2012. Each warrant will have an exercise price of $5.50 per share, will be exercisable upon separation of the units and will expire five years from the date of issuance.
  • [F3]Consists of 25,576 shares of common stock and 12,788 shares of common stock issuable upon exercise of warrants.

Documents

1 file
  • 4
    a4.xmlPrimary

    4